ARTICLE | Company News
Medarex, NovImmune in antibody deal
May 17, 2001 7:00 AM UTC
MEDX will develop human monoclonal antibodies using its UltiMAb technology against targets identified by NovImmune (Geneva, Switzerland). NovImmune will develop and commercialize resulting products. M...